Pharma Companies
-
October 16, 2020, Friday
3 firms get clinical trial approval for alternative Covid-19 drugs
The drug 2-DG is not yet an approved drug, but there have been multiple studies across the globe for treatment of cancers
-
October 16, 2020, Friday
Roche Holding sales disappoint as drugs decline eclipses Covid-19 tests
The Swiss drugmaker's revenue rose 1% to 14.7 billion francs ($16.1 billion), the company said
-
October 11, 2020, Sunday
Smaller pharma firms post faster domestic sales growth in September
Barring Cipla and Glenmark, whose sales have grown in double digits due to demand for their Covid-19 drugs like favipiravir, ...
-
October 04, 2020, Sunday
PE/VC investments in pharma companies grow 3.5X in 2020, cross $1 bn mark
The reputation and relationships have helped pharma industry raise huge amounts of PE capital in 2020.
-
October 03, 2020, Saturday
Patented molecules clock a high growth rate in Indian cardiovascular market
In January 2020, the Delhi High Court granted an injunction restraining domestic companies such as Cipla, Torrent, Emcure, and ...
-
October 02, 2020, Friday
Revised, more industry-friendly PLI scheme for bulk drugs on the cards
Industry says move will mean lower spends and reduced dependence on China
-
September 26, 2020, Saturday
Credit metrics of leading pharma companies to remain stable: ICRA
The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic nature of ...
-
September 24, 2020, Thursday
Syngene: Investors with long term view should look at the stock on dips
While Covid-19 could is a near term opportunity, contract manufacturing is the key medium-term trigger
-
September 22, 2020, Tuesday
Lupin launches generic Divalproex Sodium tablets for bipolar disorder in US
According to IQVIA MAT July 2020 data, Divalproex Sodium extended-release tablets USP had annual sales of approximately USD 130 ...
-
September 13, 2020, Sunday
Gilead nears deal to buy Immunomedics for more than $20 billion: Report
Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged ...
